CONTRACT PHARMACAL FDA Approval ANDA 073254

ANDA 073254

CONTRACT PHARMACAL

FDA Drug Application

Application #073254

Application Sponsors

ANDA 073254CONTRACT PHARMACAL

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL2MG0LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP1993-07-30
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1994-05-27
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1995-07-25
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1994-08-30
LABELING; LabelingSUPPL5AP1996-02-28
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1996-02-28
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1996-08-26
LABELING; LabelingSUPPL8AP1998-03-09
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1999-08-16
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2000-09-21

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL10Null0

CDER Filings

CONTRACT PHARMACAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 73254
            [companyName] => CONTRACT PHARMACAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOPERAMIDE HYDROCHLORIDE","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LOPERAMIDE HYDROCHLORIDE","submission":"LOPERAMIDE HYDROCHLORIDE","actionType":"2MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.